Keywords: Eisai, Novartis, COPD drugs, Co-promotion, Japan, Onbrez

Eisai in deal with Novartis to co-promote COPD drugs in Japan

Article | 21 November 2011

Print This

Japanese drugmaker Eisai (TYO: 4523) has entered into a Japan co-promotion agreement with the local subsidiary of Swiss major Novartis (NONV: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in